Biomedical research and development

                                   
The "FUTURE HEALTHCARE INDUSTRY PARK" is invested, constructed and operated by Wuxi Huishan Technology Innovation Group and Yuqi Street. The park covers an area of about 130 acres, with a total investment of 1.2 billion yuan. With life and health as the main direction, the park covers future functional health products, bioengineering products and small equipment production related to the industry.The total construction area of the Industrial Park is 170,000 square meters, integrating production, R&D, office, talent apartments and other formats. The facilities include a 15,000-square-meter R&D building, eighteen multi-story, high-standard production workshops totaling about 140,000 square meters, and a 15,000-square-meter talent apartment building. The park continues the group's collaboration with leading fund companies that have long invested in the healthcare sector, including Source Code Capital, Fosun Venture, Highlight Capital, and China Capital. This forms a "Park + Fund" model, thus promoting the establishment of high-quality enterprises and projects within the park. Wuxi Huishan Technology Innovation Group in collaboration with JOINN Laboratories and Wuxi Venture Capital, has established the Wuxi Jinyifu New Biopharmaceutical Fund with a total size of no less than 5 billion yuan, with an initial phase of 1 billion yuan. JOINN Laboratories will set up the JOINN Huishan New Drug Discovery Public Service Platform in the park, which will include a drug evaluation platform, a laboratory animal platform, and a drug discovery platform. Leveraging JOINN’s strengths as one of the top three CRO (Contract Research Organization) companies in China’s biopharmaceutical industry, the platform will support and promote the local R&D and industrialization of biopharmaceuticals.